Evidence map›Paper›PMID 22629233›Full record

ArticlePLoS medicine2012

A prescription for improving drug formulary decision making.

Gordon D Schiff, William L Galanter, Jay Duhig, Michael J Koronkowski, Amy E Lodolce, Pam Pontikes, John Busker, Daniel Touchette, Surrey Walton, Bruce L Lambert

Abstract read
In one paragraph

Article in PLoS medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.P & T : a peer-reviewed journal for formulary management · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gordon D SchiffBrigham and Woman's Hospital, Harvard Medical School, Boston, MA, USA. gschiff@partners.org
William L Galanter
Jay Duhig
Michael J Koronkowski
Amy E Lodolce
Pam Pontikes
John Busker
Daniel Touchette
Surrey Walton
Bruce L Lambert

Funding

Tools for Optimizing Prescribing, Monitoring and EducationU18HS016973 · AHRQ · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAMBERT, BRUCE L. · 2007 to 2010
$4.0M
AHRQ HHS U18 HS016973AHRQ HHS U18HS016973
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChecklistDecision MakingFormularies as TopicPrescription DrugsFormularies, Hospital as TopicHumansPharmacy and Therapeutics CommitteeUnited StatesPrescription Drugs

Identifiers

PMID22629233
PMCPMC3358338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.